Medical Cannabis Market Research Report - Forecast till 2027

Medical Cannabis Market: Information By Product Type (Solid, Dissolvable/Powders, Oil & Ointment, Creams), Derivative (Cannabidiol, Tetrahydrocannabinol), Route of Administration (Inhalation, Oral, Topical), Application (Pain Management, Neurological Health Management, Mental Health Management), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Forecast till 2027

ID: MRFR/HC/6896-CR | August 2021 | Region: Global | 146 pages

Medical Cannabis Market Overview


The worldwide Medical Cannabis Market Size is expected to cross USD 33,210.21 million by 2027 at a CAGR of 18.14%.


You must know that Marijuana is a plant containing a synthetic compound. It is also known as cannabis that has effective healing properties. The best thing about this plant is that it is utilized as a crude material by different drug organizations to make drugs for different remedial applications. The legitimate utilization of cannabis for medical reasons is expanding due to its effective benefits. However, it shifts across nations because of the conveyance, ownership, development, and clinical signs for its utilization. 


The development of the Medical Cannabis Market is driven by different factors like an increment in the utilization of cannabis, a rising predominance of ongoing infections, and much more. The expanding legitimization of Medical Cannabis in various nations ascends to research and improvement of cannabinoids. Be that as it may, expanding unlawful utilization of Maryjane is relied upon to check the worldwide Market Outlook development. There are multiple uses of cannabis in the medical industry, which is driving the Medical Cannabis Market growth. 


The expanding sanctioning of the hemp plant in different nations for restorative designs are projected to give drug organizations worthwhile freedoms. And it may also reinforce the worldwide Medical Cannabis Market for its effective growth during the estimated period. The capacity of the natural plant to give alleviation from persistent torment, spewing, and rest hardships can speed up the interest in Medical Cannabis, which may help the business in the coming time frame. As per the Market Forecast, the developing use of cannabis to forestall disease will probably flood the interest for natural leaves that can fuel the exchange in the coming time frame. It is also leading to the high demand for Medical Cannabis which ultimately enhancing the growth and development of the Medical Cannabis Market Share in the best manner. 


Covid-19 Analysis


The COVID-19 pandemic has disturbed the inventory network of the executives of cannabis items. Because of the severe lockdown across the globe, the inventory of cannabis in dispensaries has diminished. The Medical Cannabis Market growth is hampered due to the covid-19 pandemic situation. Also, the COVID-19 pandemic has hit the fare Medical Cannabis business. The interruption in the inventory network caused because of lockdowns insignificant nations have influenced import just as fare business. Nonetheless, the number of patients embracing cannabis as therapy will probably increase because of the development in the predominance of ailments that require Medical Cannabis as a treatment. Apart from the pandemic situation, the market is still expected to grow in the forecasted period. 


Market Dynamics


Drivers


Intense usage of cannabis is the key player that is driving the growth of the Medical Cannabis Market.  You must know that almost 2.5% of the total populace devours to cannabis yearly. In the current decade, the utilization of cannabis has expanded all the more quickly contrasted with different substances. There has been a quick development in cannabis utilization and is just ascending in created nations like Western Europe, North America, and Australia. 


Another driver of the Medical Cannabis Market is the rising predominance of ongoing infections and other ailments. Medical Cannabis is protected and powerful for further developing indications, for example, rest problems, tension, and torment brought about by persistent sicknesses in grown-ups.


Challenges


The expanded use of cannabis in the corrective items can be viewed as a driver for the market. But due to the complex administrative construction for the use of cannabis could be a challenging factor for the Medical Cannabis market. And the ascent of the Maryjane underground market is also one of the challenging factors for the market. In order to the effective growth of the market, these challenges must be properly taken care of. 


Opportunities


The best thing about the Medical Cannabis market is that it gives subtleties of a piece of the pie, new opportunities of events, and item pipeline investigation, effect of local and confined market players, examinations openings as far as arising income pockets, changes in market guidelines, item endorsements, key choices, item dispatches, geographic extensions, and mechanical advancements on the lookout. These opportunities could be the new opening for the key players of the market for its effective growth. 


Restraints


The major restraints in the Medical Cannabis market are expanding the unlawful utilization of Cannabis. You must know that around twenty-eight percent of the worldwide populace abuse drug medications, and quite possibly the most ordinarily accessible is cannabis. Additionally, the most well-known unlawful medications utilized by adults and over were cocaine, cannabis, rapture, and amphetamine.


Cumulative growth Analysis


The development of the worldwide Medical Cannabis market is driven by different factors like an increment in the utilization of cannabis, a rising predominance of ongoing infections and other ailments, expanding legitimization of clinical pot in numerous nations, ascend in research, and advancement of cannabinoids. In any case, expanding illicit utilization of Maryjane is required to control the worldwide market development. The market is expected to develop to a great extent in the estimated period. 


Segment Overview



  • By Species


On the basis of species, the market has been segmented as cannabis Indica, Sativa, and crossbreed. Cannabis Indica overwhelms the market, holding the biggest offer in the market. Medical cannabis is normally utilized to treat sleep deprivation, loosen up the muscles, calm body agonies, cerebral pains, headaches, and much more. 



  • By Derivatives 


Based on derivatives, the market has been partitioned into cannabidiol (CBD), tetrahydrocannabinol (THC), and much more. Cannabidiol is significantly utilized for clinical purposes because of its non-crazy impact and low degrees of poisonousness. At the same time, THC is used to lessen the results of AIDS and malignant growth treatment in the best manner. 



  • By Application


The market has additionally been segmented based on applications wherein disease addresses the main classification. Another significant utilization of cannabis incorporates joint inflammation, headache, epilepsy, and much more. 



  • By End-Use 


Based on end-use, the market has been segmented into the drug business, innovative work communities, and much more. Presently, the drug business addresses the greatest end client. 



  • By Route of Administration


Based on the route of administration, the market has been segmented into oral arrangements and cases, smoking, vaporizers, topical, and others. Oral arrangements and cases address the greatest portion, representing the biggest piece of the pie.


Regional Analysis 


The Medical Cannabis market has been segmented based on region, Asia-Pacific, Americas, Europe, the Middle East, and Africa. The Americas is relied upon to be the biggest market inferable from the expanding predominance of clinical cannabis and rising per capita medical care consumption. The market in the Americas has additionally been extended into North America and Latin America, with the North American market partitioned into the US and Canada. The European Medical Cannabis market has been arranged as Western Europe and Eastern Europe.


Major Market Players


The major players of the Medical Cannabis market are mentioned below:



  • Canopy Growth Corporation (Canada)

  • GW Pharmaceuticals PLC (UK)

  • Aurora Cannabis (Canada)

  • Aphria, Inc. (Canada)

  • Maricann Inc. (Canada)

  • Tilray (Canada)

  • Cannabis Sativa Inc. (US)

  • GBSciences Inc. (US)

  • United Cannabis (US)

  • Medical Marijuana, Inc. (US)

  • CanniMed Ltd (Canada)

  • MediPharm Labs (Canada)


Recent Developments



  • In October 2016, Columbia legitimized the utilization of cannabis as a clinical treatment for different sicknesses and issues. In addition, it was additionally referenced that in November 2016 in the US, citizens in Florida, Arkansas, Montana, and North Dakota allowed drives to extend the clinical utilization of cannabis.

  • In 2016, almost 1.5 million individuals were experiencing AIDS in North America, and more than 1.7 million patients with the disease are being analyzed in the USA alone, which shows the gigantic possible market for clinical cannabis.


Report Overview



  • Market overview highlights the global recognition of market analysis overview

  • Analysis based upon covid 19

  • Explanation upon the market dynamics

  • Value chain analysis for the medical cannabis market share report.

  • Market segmentation overview

  • The regional analysis of market trends overview

  • Competitive landscape analysis

  • Recent developments of market value forecast 


The report highlights the global Medical Cannabis Market Growth development includes its revenue hike's growth potential by the end of the forecast years in 2028.



Report Scope:
Report Attribute/Metric Details
  Market Size   2027: USD 33,210.21Million
  CAGR   18.14%
  Base Year   2020
  Forecast Period   2021-2027
  Historical Data   2018 & 2019
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Product Type, Derivative, ROAApplication, Distribution Channel,and Region
  Geographies Covered   Americas, Europe, Asia-Pacific, Middle East & Africa
  Key Vendors   Canopy Growth Corporation (Canada), Cannabis Sativa, Inc. (US), GW Pharmaceuticals plc. (UK), Emerald Health Therapeutics (Canada), Tilray, Inc. (Canada), Aurora Cannabis Inc. (Canada), Cara Therapeutics (US), Medical Marijuana, Inc. (US), GB Sciences, Inc. (US), Canndoc (Israel)
  Key Market Opportunities   Improving the status of cannabis in Asian and African countries
  Key Market Drivers

  • Increasing R&D activities and financial support by various private and government organizations
  • Legalization of medical cannabis in various regions


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :


    The medical cannabis industry includes Product form (Powders, Solids, Ointments and creams, Oil, Others) and Derivative (Cannabidiol, Tetrahydrocannabinol)

    The Alzheimer’s disease is the largest segment on the basis of applications in the global medical cannabis market.

    Increase in consumption of cannabis in the medical sector.

    North America holds the largest share in the global medical cannabis market, followed by Europe and the Asia Pacific, respectively.

    Aphria, Inc. (Canada), Canopy Growth Corporation (Canada), Maricann Inc. (Canada), GW Pharmaceuticals PLC (UK), Tilray (Canada), Medical Marijuana, Inc. (US), Aurora Cannabis (Canada), Cannabis Sativa Inc. (US), CanniMed Ltd (Canada), United Cannabis (US), MediPharm Labs (Canada), and GBSciences Inc. (US), are some of the major players operating in the Medical cannabis market.

    The global medical cannabis market is projected to grow at approximately 15.4% CAGR during forecast period (2019-2025).



    This table of content is tentative and subject to change as the research progresses.

    Please Note:  Financial details of company cannot be provided if the information of the company is not available in public domain and or reliable source.